Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous HPC transplant for Churg-Strauss syndrome
NCT02728271Phase 1Terminated
- Start
- Apr 2016
- Primary completion
- Jul 2016
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, open-label trial of autologous hematopoietic progenitor cells in eosinophilic granulomatosis with polyangiitis (EGPA). Started Apr 2016; status: terminated.
02
Drugs
autologous hematopoietic progenitor cells
03
Conditions
eosinophilic granulomatosis with polyangiitis (EGPA)
Beyond the preview
Go deeper on NCT02728271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02728271.